These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16110059)

  • 41. My stand against DTC ads.
    Bellard BM
    Med Econ; 2004 Feb; 81(4):104. PubMed ID: 15015419
    [No Abstract]   [Full Text] [Related]  

  • 42. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 Jul; 288(1):36. PubMed ID: 12090852
    [No Abstract]   [Full Text] [Related]  

  • 43. The pharmaceutical industry's 'wonder drug'.
    Silverman WA
    Paediatr Perinat Epidemiol; 2004 Nov; 18(6):398-9. PubMed ID: 15535814
    [No Abstract]   [Full Text] [Related]  

  • 44. Advertising baldly to the public.
    Gandy W
    N Engl J Med; 1992 Jan; 326(5):350-1. PubMed ID: 1728751
    [No Abstract]   [Full Text] [Related]  

  • 45. Four drug companies breach industry's code of practice.
    Hawkes N
    BMJ; 2010 Dec; 341():c7266. PubMed ID: 21163846
    [No Abstract]   [Full Text] [Related]  

  • 46. Misrepresenting an ASHP practice standard for commercial purposes.
    Myers CE
    Am J Hosp Pharm; 1994 Sep; 51(17):2107-8. PubMed ID: 7985684
    [No Abstract]   [Full Text] [Related]  

  • 47. Traveling medicine shows: a modern update?
    Carroll-Johnson RM
    Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666
    [No Abstract]   [Full Text] [Related]  

  • 48. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
    Huh J; Cude BJ
    J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FDA considers tightening regulations for direct-to-consumer advertising.
    Vastag B
    J Natl Cancer Inst; 2005 Dec; 97(24):1806-7. PubMed ID: 16368941
    [No Abstract]   [Full Text] [Related]  

  • 50. The price of seduction: direct-to-consumer advertising of prescription drugs in the US.
    Marks JH
    N C Med J; 2003; 64(6):292-5. PubMed ID: 14983622
    [No Abstract]   [Full Text] [Related]  

  • 51. AstraZeneca reprimanded for nolvadex advertisement.
    Fintor L
    J Natl Cancer Inst; 2002 Mar; 94(5):330. PubMed ID: 11880471
    [No Abstract]   [Full Text] [Related]  

  • 52. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1997 Oct; 278(13):1054. PubMed ID: 9315751
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmaceutical ads in journals.
    Liebman M
    Ann Intern Med; 1992 Oct; 117(7):617; author reply 618-9. PubMed ID: 1524341
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmaceutical ads in journals.
    Beary JF
    Ann Intern Med; 1992 Oct; 117(7):616; author reply 618-9. PubMed ID: 1524338
    [No Abstract]   [Full Text] [Related]  

  • 55. Questions timing of publicity on new drug.
    Dorsey M
    J Am Vet Med Assoc; 1999 Mar; 214(5):623-4. PubMed ID: 10088006
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmaceutical advertising in ophthalmology.
    Kahawita SK; Casson RJ
    Clin Exp Ophthalmol; 2012 Mar; 40(2):216-7. PubMed ID: 21902791
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug company accused of breaking advertising regulations.
    Waechter F
    BMJ; 2003 May; 326(7399):1106. PubMed ID: 12763970
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmaceutic promotion and publicity: quo vadis?].
    Castillo Pérez P
    Med Clin (Barc); 1992 Sep; 99(8):305-9. PubMed ID: 1453825
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug advertisements in Indian medical journals.
    Lal A; Sharma ML
    Indian J Physiol Pharmacol; 1992 Apr; 36(2):139-40. PubMed ID: 1506082
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug ads: how much is hype?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):1-2. PubMed ID: 11682901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.